X
RGEN icon

Xponance’s Repligen RGEN Stock Holding History

Xponance’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$877K Sell
6,429
-663
-9% -$81.5K 0.01% 839
2026
Q1 		$836K Buy
7,092
+1,491
+27% +$208K 0.01% 810
2025
Q4 		$918K Sell
5,601
-993
-15% -$156K 0.01% 716
2025
Q3 		$881K Buy
6,594
+31
+0.5% +$3.77K 0.01% 749
2025
Q2 		$816K Sell
6,563
-426
-6% -$54.2K 0.01% 764
2025
Q1 		$889K Buy
6,989
+50
+0.7% +$7.7K 0.01% 734
2024
Q4 		$999K Buy
6,939
+459
+7% +$65.8K 0.01% 721
2024
Q3 		$964K Sell
6,480
-2,525
-28% -$362K 0.01% 712
2024
Q2 		$1.14M Sell
9,005
-2,123
-19% -$333K 0.01% 647
2024
Q1 		$2.05M Buy
11,128
+2,229
+25% +$424K 0.02% 513
2023
Q4 		$1.6M Sell
8,899
-63
-0.7% -$9.81K 0.02% 534
2023
Q3 		$1.43M Sell
8,962
-70
-0.8% -$11.4K 0.02% 548
2023
Q2 		$1.28M Sell
9,032
-1,907
-17% -$306K 0.02% 584
2023
Q1 		$1.84M Sell
10,939
-66
-0.6% -$11.8K 0.03% 477
2022
Q4 		$1.86M Buy
11,005
+845
+8% +$153K 0.03% 452
2022
Q3 		$1.9M Sell
10,160
-2
-0% -$422 0.04% 398
2022
Q2 		$1.65M Sell
10,162
-848
-8% -$134K 0.03% 421
2022
Q1 		$2.07M Sell
11,010
-129
-1% -$24.5K 0.03% 365
2021
Q4 		$2.95M Buy
11,139
+12
+0.1% +$3.23K 0.05% 297
2021
Q3 		$3.22M Sell
11,127
-427
-4% -$110K 0.06% 251
2021
Q2 		$2.31M Buy
11,554
+216
+2% +$41.9K 0.04% 334
2021
Q1 		$2.2M Buy
11,338
+321
+3% +$65.8K 0.05% 294
2020
Q4 		$2.11M Buy
11,017
+56
+0.5% +$10.2K 0.05% 307
2020
Q3 		$1.62M Buy
10,961
+1,267
+13% +$181K 0.04% 322
2020
Q2 		$1.2M Buy
+9,694
New +$1.14M 0.03% 350

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Xponance's RGEN Position: Q2 2026 in Review

Xponance reduced its Repligen (RGEN) stake by 9.3% in Q2 2026, selling an estimated $81.5K and leaving 6,429 shares worth $877K. The position accounts for 0.01% of the portfolio, ranked #839.

Xponance first reported a position in RGEN in Q2 2020 and has held it in 25 quarters since. The position peaked at $3.22M in Q3 2021. 480 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Xponance held 6,429 shares of Repligen worth $877K as of Q2 2026.
  • Xponance sold 663 Repligen shares in Q2 2026, an estimated $81.5K.
  • Repligen made up 0.01% of Xponance's portfolio in Q2 2026, its #839 holding.
  • Xponance first reported a position in Repligen in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Repligen position peaked at $3.22M in Q3 2021.
  • 480 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.